12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Galen, Nuvo sales and marketing update

Nuvo and its Zars Pharma Inc. subsidiary granted Galen's Galen U.S. Inc. subsidiary exclusive, U.S. rights to commercialize Nuvo's Synera patch. The license is for Synera's approved indication...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >